Cite
HARVARD Citation
Hagiwara, M. et al. (2019). Healthcare utilization and costs among relapsed or refractory multiple myeloma patients on carfilzomib or pomalidomide as monotherapy or in combination with dexamethasone. Journal of medical economics. pp. 818-829. [Online].